Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | 35.2x - 38.9x | 37.0x |
| Selected Fwd EBIT Multiple | 29.7x - 32.8x | 31.2x |
| Fair Value | ₹25,834 - ₹28,502 | ₹27,168 |
| Upside | -12.5% - -3.5% | -8.0% |
| Benchmarks | Ticker | Full Ticker |
| Glenmark Pharmaceuticals Limited | 532296 | BSE:532296 |
| Lupin Limited | 500257 | BSE:500257 |
| Mankind Pharma Limited | 543904 | BSE:543904 |
| Alembic Pharmaceuticals Limited | 533573 | BSE:533573 |
| Medico Remedies Limited | 540937 | BSE:540937 |
| Abbott India Limited | ABBOTINDIA | NSEI:ABBOTINDIA |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| 532296 | 500257 | 543904 | 533573 | 540937 | ABBOTINDIA | ||
| BSE:532296 | BSE:500257 | BSE:543904 | BSE:533573 | BSE:540937 | NSEI:ABBOTINDIA | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | 2.8% | 10.1% | 19.9% | -2.3% | 39.4% | 18.4% | |
| 3Y CAGR | -5.6% | 16.5% | 10.6% | -20.1% | 40.8% | 16.7% | |
| Latest Twelve Months | 132.5% | 71.4% | 23.1% | 17.0% | 15.2% | 13.7% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 13.6% | 10.1% | 21.2% | 14.7% | 4.4% | 21.2% | |
| Prior Fiscal Year | 9.8% | 5.1% | 18.2% | 7.7% | 4.9% | 21.1% | |
| Latest Fiscal Year | 11.4% | 13.9% | 20.8% | 10.6% | 6.9% | 23.6% | |
| Latest Twelve Months | 18.7% | 18.8% | 21.1% | 11.2% | 6.6% | 24.4% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 3.05x | 4.09x | 8.37x | 2.89x | 3.00x | 10.15x | |
| EV / LTM EBITDA | 13.9x | 17.7x | 33.7x | 19.2x | 36.1x | 40.9x | |
| EV / LTM EBIT | 16.3x | 21.7x | 39.6x | 25.9x | 45.4x | 41.7x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | 16.3x | 25.9x | 45.4x | ||||
| Historical EV / LTM EBIT | 37.4x | 39.1x | 42.8x | ||||
| Selected EV / LTM EBIT | 35.2x | 37.0x | 38.9x | ||||
| (x) LTM EBIT | 15,210 | 15,210 | 15,210 | ||||
| (=) Implied Enterprise Value | 535,066 | 563,228 | 591,389 | ||||
| (-) Non-shareholder Claims * | 10,452 | 10,452 | 10,452 | ||||
| (=) Equity Value | 545,518 | 573,680 | 601,841 | ||||
| (/) Shares Outstanding | 21.2 | 21.2 | 21.2 | ||||
| Implied Value Range | 25,672.29 | 26,997.58 | 28,322.86 | ||||
| FX Rate: INR/INR | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 25,672.29 | 26,997.58 | 28,322.86 | 29,540.90 | |||
| Upside / (Downside) | -13.1% | -8.6% | -4.1% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | 532296 | 500257 | 543904 | 533573 | 540937 | ABBOTINDIA | |
| Enterprise Value | 427,488 | 922,675 | 956,468 | 183,372 | 4,567 | 617,272 | |
| (+) Cash & Short Term Investments | 18,202 | 29,123 | 47,267 | 1,290 | 15 | 11,057 | |
| (+) Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Debt | (17,808) | (34,425) | (4,821) | (10,664) | (114) | (605) | |
| (-) Other Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 427,882 | 917,373 | 998,915 | 173,998 | 4,468 | 627,724 | |
| (/) Shares Outstanding | 282.2 | 456.5 | 412.6 | 196.6 | 83.0 | 21.2 | |
| Implied Stock Price | 1,516.30 | 2,009.40 | 2,421.15 | 885.20 | 53.84 | 29,540.90 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 1,516.30 | 2,009.40 | 2,421.15 | 885.20 | 53.84 | 29,540.90 | |
| Trading Currency | INR | INR | INR | INR | INR | INR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |